Patents

US 9730981 B2: Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids

Granted
2017-08-15
Filed
2013-05-21 application 13899198
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Nucleic acid vectors encoding light-gated cation-selective membrane channels, in particular channelrhodopsin-2 (Chop2), converted inner retinal neurons to photosensitive cells in photoreceptor-degenerated retina in an animal model. Such treatment restored visual perception and various aspects of vision. A method of restoring light sensitivity to a retina of a subject suffering from vision loss due to photoreceptor degeneration, as in retinitis pigmentosa or macular degeneration, is provided. The method comprises delivering to the subject by intravitreal or subretinal injection, the above nucleic acid vector which comprises an open reading frame encoding a rhodopsin, to which is operatively linked a promoter and transcriptional regulatory sequences, so that the nucleic acid is expressed in inner retinal neurons. These cells, normally light-insensitive, are converted to a light-sensitive state and transmit visual information to the brain, compensating for the loss, and leading to restoration of various visual capabilities.

Source: PVGPATDIS, file of 2026-04-10 (ipg170815.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Salus University 5 patentsUS company or organizationCheltenham, PASalus University College or university EXACT high confidence: identical full name and state
SALUS UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10
Wayne State University 333 patentsUS company or organizationDetroit, MIWayne State University College or university EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Zhuo-Hua PanTroy, MI12PVGPATDIS, file of 2026-04-10
Alexander M. DizhoorDresher, PA3Person page FUZZY high confidencePVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/177PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P27/02PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/705PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2017-03-17Assignment
Assignment of assignor's interest
DIZHOOR, ALEXANDER M. signed 2009-07-14SALUS UNIVERSITY ELKINS PARK, PA41618/308PASDL, file of 2026-10-15
2017-03-17Assignment
Assignment of assignor's interest
PAN, ZHUO-HUA signed 2009-08-14WAYNE STATE UNIVERSITY DETROIT, MI41618/306PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.